|
|
Bayer Group | 2000 | 1999 | Change in % | |
---|---|---|---|---|
Sales | • million | 30,971 | 27,320 | + 13.4 |
Operating result | • million | 3,287 | 3,357 | − 2.1 |
Income before income taxes | • million | 2,990 | 2,836 | + 5.4 |
Net income | • million | 1,816 | 2,002 | − 9.3 |
Gross cash flow | • million | 4,164 | 3,192 | + 30.5 |
Stockholders/ equity | • million | 16,377 | 15,182 | + 7.9 |
Total assets | • million | 36,451 | 31,279 | + 16.5 |
Capital expenditures | • million | 2,647 | 2,632 | + 0.6 |
Employees | at year end | 122,100 | 120,400 | + 1.4 |
Personnel expenses | • million | 7,735 | 7,549 | + 2.5 |
Research and development expenses | • million | 2,393 | 2,252 | + 6.3 |
Bayer AG | 2000 | 1999 | Change in % | |
---|---|---|---|---|
Total dividend payment | • million | 1,022 | 949 | + 7.7 |
Dividend per share | • | 1.40 | 1.30 | + 7.7 |
Tax credit | • | 0.45 | 0.08 | - |
Source: http://www.bayer.com/geschaeftsbericht2000//eng/index.html |
Bayer Group ( • million) | 1996 | 1997 | 1998 | 1999 | 2000 |
---|---|---|---|---|---|
Net sales | 24,853 | 28,124 | 28,062 | 27,320 | 30,971 |
Sales outside Germany | 82,2% | 83,9% | 83,6% | 84,3% | 85,6% |
Sales of foreign consolidated companies | 65,4% | 67,0% | 67,5% | 68,3% | 69,0% |
Operating result | 2,306 | 3,077 | 3,155 | 3,357 | 3,287 |
Income before income taxes | 2,282 | 2,611 | 2,728 | 2,836 | 2,990 |
Income after taxes | 1,405 | 1,509 | 1,615 | 2,018 | 1,842 |
Noncurrent assets | 10,689 | 12,230 | 13,981 | 15,614 | 20,344 |
Intangible assets | 729 | 1,051 | 1,909 | 2,213 | 4,843 |
Property, plant and equipment | 8,974 | 10,307 | 10,970 | 11,986 | 13,345 |
Investment | 986 | 872 | 1,102 | 1,415 | 2,156 |
Current assets | 14,593 | 15,467 | 15,396 | 15,665 | 16,107 |
Inventories | 5,144 | 5,424 | 5,781 | 4,992 | 6,095 |
Receivables | 7,028 | 7,588 | 7,894 | 7,533 | 9,308 |
Liquid assets | 2,421 | 2,455 | 1,721 | 3,140 | 704 |
Stockholders' equity | 10,765 | 12,232 | 12,779 | 15,182 | 16,377 |
Capital stock of Bayer AG | 1,851 | 1,867 | 1,867 | 1,870 | 1,870 |
Capital reserves and retained earnings | 7,287 | 8,638 | 9,087 | 11,134 | 12,454 |
Net income | 1,393 | 1,504 | 1,614 | 2,002 | 1,816 |
Minority stockholders' interest | 234 | 223 | 211 | 176 | 237 |
Liabilities | 14,517 | 15,465 | 16,598 | 16,097 | 20,074 |
Provisions | 7,057 | 7,275 | 7,271 | 6,714 | 7,163 |
Other liabilities | 7,460 | 8,190 | 9,327 | 9,383 | 12,911 |
Total assets | 25,282 | 27,697 | 29,377 | 31,279 | 36,451 |
Proportion of total assets | |||||
Noncurrent assets | 42.3% | 44.2% | 47.6% | 49.9% | 55.8% |
Current assets | 57.7% | 55.8% | 52.4% | 50.1% | 44.2% |
Stockholders' equity | 42.6% | 44.2% | 43.5% | 48.5% | 44.9% |
Liabilities | 57.4% | 55.8% | 56.5% | 51.5% | 55.1% |
Financial obligations | 3,520 | 3,896 | 4,730 | 4,466 | 6,665 |
- Long-term | 1,615 | 2,150 | 2,404 | 2,359 | 2,803 |
- Short term | 1,905 | 1,746 | 2,326 | 2,107 | 3,862 |
Interest income(expense) - net | (44) | (157) | (179) | (196) | (311) |
Noncurrent assets financed by stockholders' equity | 100.7% | 100.0% | 91.4% | 97.2% | 80.5% |
Noncurrent assets and inventories financed by stockholders' equity and long-term liabilities | 114.9% | 115.5% | 106.1% | 112.3% | 93.9% |
Return on sales | 9.3% | 11.0% | 12.6% | 11.2% | 11.1% |
Return on stockholders' equit | 14.0% | 13.1% | 12.9% | 14.4% | 11.7% |
Source: http://www.bayer.com/geschaeftsbericht2000//eng/index.html |
|
|